Chicago Capital Management’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,816
Closed -$69K 45
2019
Q1
$69K Buy
+11,816
New +$40.3K 0.03% 23

Chicago Capital Management's IMDZ Position: Q2 2019 in Review

Chicago Capital Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 11,816 shares — an estimated $69K sold.

Chicago Capital Management first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $69K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

  • Chicago Capital Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
  • Chicago Capital Management sold 11,816 Immune Design Corp. shares in Q2 2019, an estimated $69K.
  • Chicago Capital Management first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
  • Chicago Capital Management's Immune Design Corp. position peaked at $69K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Chicago Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.